NCODA Logo

EGFR Inhibitors

Written by: Danny Olszta, PharmD, BCOP Jolliet Oncology Hematology Associates Download Here For patients with Non‐Small Cell Lung Cancer (NSCLC) that have sensitizing epidermal growth factor receptor (EGFR) mutations (most commonly exon 19 deletions or exon 21 L858R...